Trial
NCT03941834
Trial for Treatment Refractory Trigeminal Neuralgia
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Pfizer
Collaborators
—
Condition
Trigeminal Neuralgia
Intervention
Rimegepant
Why stopped
Strategic decision to discontinue the study based on adjusted clinical development plan. This decision is not based on any safety concerns.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-06-10